Sarepta Therapeutics (SRPT) will update investors on the regulatory progress of eteplirsen...

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor

Sarepta Therapeutics (SRPT) will update investors on the regulatory progress of eteplirsen tomorrow on a conference call scheduled for 8 a.m. EDT. Shares -2% AH. (PR)